Temat: "Drug Administration Schedule" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Successful management of hemodialysis-dependent refractory myeloma with modified daratumumab, bortezomib and dexamethasone regimen.
Autorzy :: Mizuno S; Department of Nephrology, Japan Community Health Care Organization Sendai Hospital, 3-16-1, Tsutsumimachi, Aoba-Ku, Sendai, Miyagi, 981-8501, Japan. .
Kitayama C; Department of Nephrology, Japan Community Health Care Organization Sendai Hospital, 3-16-1, Tsutsumimachi, Aoba-Ku, Sendai, Miyagi, 981-8501, Japan.
Yamaguchi K; Department of Nephrology, Japan Community Health Care Organization Sendai Hospital, 3-16-1, Tsutsumimachi, Aoba-Ku, Sendai, Miyagi, 981-8501, Japan.
Sanada S; Department of Nephrology, Japan Community Health Care Organization Sendai Hospital, 3-16-1, Tsutsumimachi, Aoba-Ku, Sendai, Miyagi, 981-8501, Japan.
Sato T; Department of Nephrology, Japan Community Health Care Organization Sendai Hospital, 3-16-1, Tsutsumimachi, Aoba-Ku, Sendai, Miyagi, 981-8501, Japan.; Pokaż więcej
Źródło :: International journal of hematology [Int J Hematol] 2020 Dec; Vol. 112 (6), pp. 860-863. Date of Electronic Publication: 2020 Jul 24.
Typ publikacji :: Case Reports; Journal Article
MeSH Terms :: Drug Administration Schedule*
Renal Dialysis*
Acute Kidney Injury/*etiology
Acute Kidney Injury/*therapy
Antibodies, Monoclonal/*administration & dosage
Bortezomib/*administration & dosage
Dexamethasone/*administration & dosage
Multiple Myeloma/*complications
Aged ; Drug Therapy, Combination ; Female ; Humans ; Multiple Myeloma/immunology ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: [The best time for a medication: how to sweeten the pill ?]
Autorzy :: Nachar C; Service de pharmacie, CHUV, 1011 Lausanne.
Perrottet N; Service de pharmacie, CHUV, 1011 Lausanne.
Garnier A; Service de médecine interne, CHUV, 1011 Lausanne.; Pokaż więcej
Transliterated Title :: Le bon moment pour un médicament: comment faire passer la pilule ?
Źródło :: Revue medicale suisse [Rev Med Suisse] 2020 Nov 25; Vol. 16 (716), pp. 2254-2258.
Typ publikacji :: Journal Article
MeSH Terms :: Drug Administration Schedule*
Drug-Related Side Effects and Adverse Reactions/*prevention & control
Pharmaceutical Preparations/*administration & dosage
Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Challenges in Protocol Development and Interpretation of the Schistosomiasis Consortium for Operational Research and Evaluation Intervention Studies.
Autorzy :: King CH; Schistosomiasis Consortium for Operational Research and Evaluation, Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia.; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio.
Kittur N; Schistosomiasis Consortium for Operational Research and Evaluation, Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia.
Wiegand RE; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland.; Parasitic Diseases Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia.
Shen Y; Department of Epidemiology & Biostatistics, University of Georgia, Athens, Georgia.
Ge Y; Department of Epidemiology & Biostatistics, University of Georgia, Athens, Georgia.
Whalen CC; Department of Epidemiology & Biostatistics, University of Georgia, Athens, Georgia.
Campbell CH; Schistosomiasis Consortium for Operational Research and Evaluation, Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia.
Hattendorf J; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland.
Binder S; Schistosomiasis Consortium for Operational Research and Evaluation, Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia.; Pokaż więcej
Źródło :: The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2020 Jul; Vol. 103 (1_Suppl), pp. 36-41.
Typ publikacji :: Journal Article; Randomized Controlled Trial
MeSH Terms :: Drug Administration Schedule*
Mass Drug Administration*
Schistosomiasis/*drug therapy
Africa South of the Sahara/epidemiology ; Animals ; Anthelmintics/therapeutic use ; Humans ; Praziquantel/therapeutic use ; Prevalence ; Research Design ; Schistosoma haematobium/drug effects ; Schistosoma mansoni/drug effects ; Schistosomiasis/epidemiology ; Schistosomiasis/transmission
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Improvement of medication adherence with simplified once-daily immunosuppressive regimen in stable kidney transplant recipients: A prospective cohort study.
Autorzy :: Oh CK; Department of Surgery, Ajou University School of Medicine, Suwon, South Korea.
Bang JB; Department of Surgery, Ajou University School of Medicine, Suwon, South Korea.
Kim SJ; Department of Surgery, Samsung Medical Center, Seoul, South Korea.
Huh KH; Department of Transplantation Surgery, Severance Hospital, Yonsei University Health System, Seoul, South Korea.
Kim SJ; Department of Surgery, CHA University School of Medicine, Seongnam, South Korea.
Jeon JS; Department of Nephrology, Soon Chun Hyang University Hospital, Seoul, South Korea.
Han SY; Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, South Korea.
Cho HR; Department of Surgery, Ulsan University Hospital, Ulsan, South Korea.
Kwon YJ; Department of Nephrology and Hypertension, Korea University Guro Hospital, Seoul, South Korea.
Lee SH; Department of Surgery, Ajou University School of Medicine, Suwon, South Korea. Electronic address: .
Kim YS; Department of Transplantation Surgery, Severance Hospital, Yonsei University Health System, Seoul, South Korea.; Pokaż więcej
Źródło :: Asian journal of surgery [Asian J Surg] 2020 Jun; Vol. 43 (6), pp. 660-667. Date of Electronic Publication: 2019 Jul 25.
Typ publikacji :: Journal Article; Multicenter Study
MeSH Terms :: Drug Administration Schedule*
Kidney Transplantation*
Medication Adherence*
Adrenal Cortex Hormones/*administration & dosage
Immunosuppressive Agents/*administration & dosage
Sirolimus/*administration & dosage
Tacrolimus/*administration & dosage
Adrenal Cortex Hormones/adverse effects ; Adult ; Cohort Studies ; Female ; Humans ; Immunosuppressive Agents/adverse effects ; Male ; Middle Aged ; Patient Outcome Assessment ; Prospective Studies ; Sirolimus/adverse effects ; Surveys and Questionnaires ; Tacrolimus/adverse effects ; Time Factors ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Standardized, Patient-specific, Postoperative Opioid Prescribing After Inpatient Orthopaedic Surgery.
Autorzy :: Chen EY; From the Department of Orthopaedic Surgery, Boston Medical Center (Dr. Chen and Dr. Tornetta), the Boston University School of Medicine (Ms. Betancourt, Ms. Li, Ms. Trucks, and Dr. Tornetta), Boston, MA, and the Department of Orthopaedic Surgery, Lahey Hospital and Medical Center, Burlington, MA (Dr. Marcantonio).
Betancourt L
Li L
Trucks E
Marcantonio A
Tornetta P 3rd; Pokaż więcej
Źródło :: The Journal of the American Academy of Orthopaedic Surgeons [J Am Acad Orthop Surg] 2020 Apr 01; Vol. 28 (7), pp. e304-e318.
Typ publikacji :: Journal Article
MeSH Terms :: Drug Administration Schedule*
Inpatients*
Orthopedic Procedures*
Analgesics, Opioid/*administration & dosage
Drug Prescriptions/*standards
Pain, Postoperative/*drug therapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Patient Discharge ; Postoperative Period ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Treatment of latent tuberculosis infection with short-course regimens in potential living kidney donors.
Autorzy :: Simkins J; Division of Infectious Diseases, Department of Medicine, University of Miami School of Medicine, Miami, Florida.
Donato-Santana C; Division of Infectious Diseases, Department of Medicine, University of Miami School of Medicine, Miami, Florida.
Morris MI; Division of Infectious Diseases, Department of Medicine, University of Miami School of Medicine, Miami, Florida.
Abbo LM; Division of Infectious Diseases, Department of Medicine, University of Miami School of Medicine, Miami, Florida.
Camargo JF; Division of Infectious Diseases, Department of Medicine, University of Miami School of Medicine, Miami, Florida.
Anjan S; Division of Infectious Diseases, Department of Medicine, University of Miami School of Medicine, Miami, Florida.
Natori Y; Division of Infectious Diseases, Department of Medicine, University of Miami School of Medicine, Miami, Florida.
Guerra G; Division of Nephrology, Department of Medicine, University of Miami School of Medicine, Miami, Florida.; Pokaż więcej
Źródło :: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2020 Apr; Vol. 22 (2), pp. e13244. Date of Electronic Publication: 2020 Jan 21.
Typ publikacji :: Journal Article
MeSH Terms :: Drug Administration Schedule*
Kidney*
Kidney Transplantation*
Living Donors*
Latent Tuberculosis/*drug therapy
Adult ; Antibiotics, Antitubercular/therapeutic use ; Humans ; Interferon-gamma Release Tests ; Latent Tuberculosis/diagnosis ; Male ; Middle Aged ; Mycobacterium tuberculosis/drug effects ; Prevalence ; Retrospective Studies ; Rifampin/analogs & derivatives ; Rifampin/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A.
Autorzy :: Tiede A; Hematology, Hemostasis, Oncology and Stem Cell Transplantation Unit, Hannover Medical School, Hannover, Germany.
Cid AR; Thrombosis and Haemostasis Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Goldmann G; Institute of Experimental Haematology and Transfusion Medicine, University of Bonn, Bonn, Germany.
Jiménez-Yuste V; Hospital Universitario La Paz, Autónoma University, Madrid, Spain.
Pluta M; Quanticate Ltd, Hitchin, United Kingdom.
Lissitchkov T; Clinic of Haematology, Specialized Hospital for Active Treatment of Haematological Diseases, Sofia, Bulgaria.
May M; Clinical Research Center Hannover, Hannover Medical School, Hannover, Germany.
Matytsina I; Novo Nordisk A/S, Søborg, Denmark.
Miljic P; Clinic of Haematology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Pabinger I; Clinical Division of Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria.
Persson P; Novo Nordisk A/S, Søborg, Denmark.; Pokaż więcej
Źródło :: Thrombosis and haemostasis [Thromb Haemost] 2020 Feb; Vol. 120 (2), pp. 277-288. Date of Electronic Publication: 2019 Dec 30.
Typ publikacji :: Journal Article; Multicenter Study
MeSH Terms :: Body Mass Index*
Drug Administration Schedule*
Factor VIII/*therapeutic use
Hemophilia A/*therapy
Obesity/*complications
Thinness/*complications
Adult ; Blood Coagulation Tests ; Body Composition ; Body Weight ; Hemophilia A/complications ; Humans ; International Cooperation ; Male ; Middle Aged ; Overweight/complications ; Recombinant Proteins/therapeutic use ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
Autorzy :: Verboon C; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.
van den Berg B; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.
Cornblath DR; Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA.
Venema E; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; Department of Public Health, Erasmus MC, Rotterdam, The Netherlands.
Gorson KC; Department of Neurology, St. Elizabeth's Medical Center, Boston, Massachusetts, USA.
Lunn MP; Department of Neurology, National Hospital for Neurology and Neurosurgery, London, UK.
Lingsma H; Department of Public Health, Erasmus MC, Rotterdam, The Netherlands.
Van den Bergh P; Department of Neurology, University Clinic St. Luc, Leuven, Belgium.
Harbo T; Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Bateman K; Department of Neurology, University of Cape Town, Cape Town, South Africa.
Pereon Y; Department of Clinical Neurophysiology, Reference Centre for NMD, Nantes University Hospital, Nantes, France.
Sindrup SH; Department of Neurology, Odense University Hospital, Odense, Denmark.
Kusunoki S; Department of Neurology, Kindai University Faculty of Medicine, Osaka, Japan.
Miller J; Department of Neurology, Royal Victoria Infirmary, Newcastle, UK.
Islam Z; Department of Laboratory Sciences and Services Division, The International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Hartung HP; Department of Neurology, Heinrich Heine University, Düsseldorf, Germany.
Chavada G; Department of Neurology, University of Glasgow, Glasgow, UK.
Jacobs BC; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC, Rotterdam, The Netherlands.
Hughes RAC; MRC Centre for Neuromuscular Diseases, National Hospital for Neurology and Neurosurgery, London, UK.
van Doorn PA; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands .; Pokaż więcej
Corporate Authors :: IGOS Consortium
Źródło :: Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2020 Feb; Vol. 91 (2), pp. 113-121. Date of Electronic Publication: 2019 Oct 05.
Typ publikacji :: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :: Drug Administration Schedule*
Guillain-Barre Syndrome/*drug therapy
Immunoglobulin G/*therapeutic use
Immunoglobulins, Intravenous/*therapeutic use
Adult ; Aged ; Disability Evaluation ; Female ; Guillain-Barre Syndrome/diagnosis ; Humans ; Immunoglobulin G/administration & dosage ; Immunologic Factors/therapeutic use ; Male ; Middle Aged ; Prognosis ; Time Factors ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: NOAC Adherence of Patients with Atrial Fibrillation in the Real World: Dosing Frequency Matters?
Autorzy :: Hwang J; Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, South Korea.
Han S; Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, South Korea.
Bae HJ; Division of Cardiology, Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu, South Korea.
Jun SW; Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, South Korea.
Choi SW; Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, South Korea.
Lee CH; Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, South Korea.
Kim IC; Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, South Korea.
Cho YK; Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, South Korea.
Park HS; Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, South Korea.
Yoon HJ; Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, South Korea.
Kim H; Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, South Korea.
Nam CW; Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, South Korea.
Hur SH; Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, South Korea.
Lee SH; Division of Cardiology, Department of Internal Medicine, SM Christianity Hospital, Pohang, South Korea.; Pokaż więcej
Źródło :: Thrombosis and haemostasis [Thromb Haemost] 2020 Feb; Vol. 120 (2), pp. 306-313. Date of Electronic Publication: 2019 Oct 28.
Typ publikacji :: Journal Article; Observational Study
MeSH Terms :: Drug Administration Schedule*
Medication Adherence*
Anticoagulants/*administration & dosage
Atrial Fibrillation/*drug therapy
Administration, Oral ; Aged ; Cross-Sectional Studies ; Dabigatran/administration & dosage ; Female ; Humans ; Male ; Middle Aged ; Pyrazoles/administration & dosage ; Pyridines/administration & dosage ; Pyridones/administration & dosage ; Rivaroxaban/administration & dosage ; Stroke/prevention & control ; Surveys and Questionnaires ; Thiazoles/administration & dosage
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Failures of once-a-week trimethoprim-sulfamethoxazole prophylaxis in children undergoing allogeneic hematopoietic stem cell transplant.
Autorzy :: Castagnola E; Istituto Giannina Gaslini, Ospedale Pediatrico IRCCS, Genova, Italy.
Mesini A; Istituto Giannina Gaslini, Ospedale Pediatrico IRCCS, Genova, Italy.
Saffioti C; Istituto Giannina Gaslini, Ospedale Pediatrico IRCCS, Genova, Italy.
Moscatelli A; Istituto Giannina Gaslini, Ospedale Pediatrico IRCCS, Genova, Italy.
Pierri F; Istituto Giannina Gaslini, Ospedale Pediatrico IRCCS, Genova, Italy.
Giardino S; Istituto Giannina Gaslini, Ospedale Pediatrico IRCCS, Genova, Italy.
Faraci M; Istituto Giannina Gaslini, Ospedale Pediatrico IRCCS, Genova, Italy.; Pokaż więcej
Źródło :: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2020 Feb; Vol. 22 (1), pp. e13231. Date of Electronic Publication: 2019 Dec 27.
Typ publikacji :: Journal Article
MeSH Terms :: Drug Administration Schedule*
Antifungal Agents/*administration & dosage
Hematopoietic Stem Cell Transplantation/*adverse effects
Pneumonia, Pneumocystis/*prevention & control
Trimethoprim, Sulfamethoxazole Drug Combination/*administration & dosage
Child ; Humans ; Immunocompromised Host ; Pneumocystis carinii ; Treatment Failure
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study.
Autorzy :: Ohashi Y; Ehime University, Dogo-Himata, Matsuyama, Ehime, Japan.
Munesue M; Santen Pharmaceutical Co., Ltd, Ofukacho, Kita-ku, Osaka, Japan. .
Shimazaki J; Tokyo Dental College Ichikawa General Hospital, Ichikawa, Chiba, Japan.
Takamura E; School of Medicine, Tokyo Women's Medical University, Kawada-cho, Shinjuku-ku, Tokyo, Japan.
Yokoi N; Kyoto Prefectural University of Medicine, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, Japan.
Watanabe H; Kansai Rosai Hospital, Inabaso, Amagasaki, Hyogo, Japan.
Nomura A; Santen Pharmaceutical Co., Ltd, Ofukacho, Kita-ku, Osaka, Japan.
Shimada F; Santen Pharmaceutical Co., Ltd, Ofukacho, Kita-ku, Osaka, Japan.; Pokaż więcej
Źródło :: Advances in therapy [Adv Ther] 2020 Feb; Vol. 37 (2), pp. 707-717. Date of Electronic Publication: 2019 Dec 13.
Typ publikacji :: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :: Drug Administration Schedule*
Dry Eye Syndromes/*drug therapy
Ophthalmic Solutions/*therapeutic use
Polyphosphates/*therapeutic use
Purinergic P2Y Receptor Agonists/*therapeutic use
Uracil Nucleotides/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Dry Eye Syndromes/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Analgesic Impact of Single-Shot Versus Continuous Femoral Nerve Block After Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
Autorzy :: Li S; Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, China.
Zhou J; Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, China.
Li X; Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, China.
Teng X; Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, China.
Li Y; Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, China.
Du C; Department of Orthopedics, The First Hospital of China Medical University, Shenyang, China.
Zhu J; Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, China. .; Pokaż więcej
Źródło :: Advances in therapy [Adv Ther] 2020 Feb; Vol. 37 (2), pp. 671-685. Date of Electronic Publication: 2020 Jan 10.
Typ publikacji :: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :: Arthroplasty, Replacement, Knee*
Drug Administration Schedule*
Analgesics, Opioid/*administration & dosage
Femoral Nerve/*drug effects
Injections/*methods
Pain Management/*methods
Pain, Postoperative/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Nerve Block/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study).
Autorzy :: Namiki T; Department of Japanese-Oriental (Kampo) Medicine, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan. .
Takayama S; Department of Kampo Medicine, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.; Department of Education and Support for Regional Medicine, Tohoku University Hospital, 1- 1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.; Department of Kampo and Integrative Medicine, Tohoku University Graduate School of Medicine, 1-2, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.
Arita R; Department of Kampo Medicine, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.; Department of Education and Support for Regional Medicine, Tohoku University Hospital, 1- 1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Ishii T; Department of Kampo Medicine, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.; Department of Education and Support for Regional Medicine, Tohoku University Hospital, 1- 1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.; Department of Kampo and Integrative Medicine, Tohoku University Graduate School of Medicine, 1-2, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.
Kainuma M; Community Medicine Education Unit, Graduate School of Medical Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Makino T; Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-Dori, Mizuho-ku, Nagoya, 467-8603, Japan.
Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Yoshino T; Center for Kampo Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Nogami T; Department of Kampo Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.
Arai M; Department of Kampo Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.
Sato J; Department of General Medicine/Family & Community Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Tanaka K; Department of Traditional Medicine, Faculty of Medicine, Toho University, 5-21-16, Omorinishi, Ota-ku, Tokyo, 143-8540, Japan.
Nakae H; Department of Emergency and Critical Care Medicine, Akita University Graduate School of Medicine, 44-2 Hasunuma Hiroomote, Akita, 010-8543, Japan.
Igari H; Department of Infectious Diseases, Chiba University Hospital, School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8677, Japan.
Ozawa Y; Biostatistics Section, Clinical Research Center, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.
Shiko Y; Biostatistics Section, Clinical Research Center, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.
Kawasaki Y; Faculty of Nursing, Japanese Red Cross College of Nursing, Tokyo, 150-0012, Japan.
Nezu M; Department of Japanese-Oriental (Kampo) Medicine, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Ito T; Akashi Clinic Kanda, 3-8, Kandaogawamachi, Chiyodaku, Tokyo, 101-0052, Japan.; Pokaż więcej
Źródło :: Trials [Trials] 2021 Jan 06; Vol. 22 (1), pp. 23. Date of Electronic Publication: 2021 Jan 06.
Typ publikacji :: Clinical Trial Protocol; Letter
MeSH Terms :: COVID-19/*prevention & control
Drugs, Chinese Herbal/*administration & dosage
Medicine, Kampo/*methods
Pandemics/*prevention & control
SARS-CoV-2/*isolation & purification
Administration, Oral ; Adult ; Aged ; COVID-19/diagnosis ; COVID-19/epidemiology ; COVID-19/virology ; COVID-19 Nucleic Acid Testing ; Drug Administration Schedule ; Drugs, Chinese Herbal/adverse effects ; Female ; Humans ; Japan/epidemiology ; Male ; Medicine, Kampo/adverse effects ; Middle Aged ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Risk Factors ; Severity of Illness Index ; Treatment Outcome ; Young Adult
: Opinia redakcyjna

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 14 14.

Tytuł :: Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
Autorzy :: Urwyler P; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
Charitos P; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
Moser S; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
Heijnen IAFM; Division of Medical Immunology, Laboratory Medicine, University Hospital Basel, Basel, Switzerland.
Trendelenburg M; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.; Department of Clinical Research and Department of Biomedicine, University of Basel, Basel, Switzerland.
Thoma R; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Sumer J; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Camacho-Ortiz A; Hospital Universitario Dr. José Eleuterio González, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Bacci MR; Department of General Practice, Centro Universitário em Saúde do ABC, Santo André, SP, Brazil.
Huber LC; Clinic for Internal Medicine, City Hospital Triemli, Zurich, Switzerland.
Stüssi-Helbling M; Clinic for Internal Medicine, City Hospital Triemli, Zurich, Switzerland.
Albrich WC; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Sendi P; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.; Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
Osthoff M; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland. .; Department of Clinical Research and Department of Biomedicine, University of Basel, Basel, Switzerland. .; Pokaż więcej
Źródło :: Trials [Trials] 2021 Jan 04; Vol. 22 (1), pp. 1. Date of Electronic Publication: 2021 Jan 04.
Typ publikacji :: Clinical Trial Protocol; Letter
MeSH Terms :: COVID-19/*drug therapy
Complement C1 Inhibitor Protein/*administration & dosage
SARS-CoV-2/*isolation & purification
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Brazil ; COVID-19/blood ; COVID-19/diagnosis ; COVID-19/virology ; Clinical Trials, Phase II as Topic ; Complement C1 Inhibitor Protein/adverse effects ; Complement C1 Inhibitor Protein/pharmacokinetics ; Drug Administration Schedule ; Female ; Humans ; Injections, Intravenous/methods ; Male ; Mexico ; Middle Aged ; Multicenter Studies as Topic ; Pilot Projects ; Randomized Controlled Trials as Topic ; Recombinant Proteins/administration & dosage ; Recombinant Proteins/adverse effects ; Recombinant Proteins/pharmacokinetics ; Severity of Illness Index ; Switzerland ; Treatment Outcome ; Young Adult
SCR Protocol :: COVID-19 drug treatment
: Opinia redakcyjna

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 15 15.

Tytuł :: Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial.
Autorzy :: Olagunju A; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria. .; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom. .
Fowotade A; Department of Medical Microbiology and Parasitology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Olagunoye A; State Specialist Hospital, Osogbo, Nigeria.
Ojo TO; Department of Community Health, Faculty of Clinical Sciences, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria.
Adefuye BO; Olabisi Onabanjo University Teaching Hospital, Sagamu, Nigeria.
Fagbamigbe AF; Department of Epidemiology and Medical Statistics, Faculty of Public Health, University of Ibadan, Ibadan, Nigeria.
Adebiyi AO; Department of Community Medicine, University of Ibadan, Ibadan, Nigeria.
Olagunju OI; Department of Surveillance and Epidemiology, Nigeria Centre for Disease Control, Abuja, Nigeria.
Ladipo OT; Oyo State Ministry of Health, Ibadan, Nigeria.
Akinloye A; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria.
Adeagbo BA; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria.
Onayade A; Department of Community Health, Faculty of Clinical Sciences, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria.
Bolaji OO; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria.
Happi C; African Centre of Excellence for Genomics of Infectious Diseases, Redeemer's University, Ede, Nigeria.
Rannard S; Department of Chemistry, School of Physical Sciences, University of Liverpool, Liverpool, United Kingdom.
Owen A; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.; Pokaż więcej
Źródło :: Trials [Trials] 2021 Jan 04; Vol. 22 (1), pp. 3. Date of Electronic Publication: 2021 Jan 04.
Typ publikacji :: Clinical Trial Protocol; Comparative Study; Letter
MeSH Terms :: Antiviral Agents/*administration & dosage
Atazanavir Sulfate/*administration & dosage
COVID-19/*drug therapy
Ritonavir/*administration & dosage
Thiazoles/*administration & dosage
Administration, Oral ; Adolescent ; Adult ; Aged ; Antiviral Agents/adverse effects ; Atazanavir Sulfate/adverse effects ; COVID-19/diagnosis ; COVID-19/virology ; COVID-19 Nucleic Acid Testing ; Clinical Trials, Phase II as Topic ; Drug Administration Schedule ; Drug Combinations ; Drug Repositioning ; Drug Therapy, Combination/adverse effects ; Drug Therapy, Combination/methods ; Female ; Humans ; Male ; Middle Aged ; Multicenter Studies as Topic ; Nigeria ; Pilot Projects ; RNA, Viral/isolation & purification ; Randomized Controlled Trials as Topic ; Ritonavir/adverse effects ; SARS-CoV-2/drug effects ; SARS-CoV-2/isolation & purification ; Severity of Illness Index ; Standard of Care ; Thiazoles/adverse effects ; Treatment Outcome ; Viral Load/drug effects ; Young Adult
SCR Protocol :: COVID-19 drug treatment
: Raport

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 16 16.

Tytuł :: Messengers of hope.
Źródło :: Nature biotechnology [Nat Biotechnol] 2021 Jan; Vol. 39 (1), pp. 1.
Typ publikacji :: Editorial
MeSH Terms :: COVID-19/*prevention & control
COVID-19 Vaccines/*administration & dosage
Drug Approval/*legislation & jurisprudence
COVID-19/immunology ; COVID-19 Vaccines/adverse effects ; COVID-19 Vaccines/chemical synthesis ; Drug Administration Schedule ; Drug Development/organization & administration ; Humans ; Injections, Intramuscular ; SARS-CoV-2/immunology ; Treatment Outcome
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Periprocedural Outcomes in Patients on Chronic Anticoagulation Undergoing Fistulograms.
Autorzy :: Paredes LG; Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston University School of Medicine, Boston, MA.
Arinze NV; Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston University School of Medicine, Boston, MA.
Farber A; Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston University School of Medicine, Boston, MA.
Garofalo D; Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston University School of Medicine, Boston, MA.
Cheng TW; Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston University School of Medicine, Boston, MA.
Levin SR; Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston University School of Medicine, Boston, MA.
Vilvendhan R; Division of Interventional Radiology, Boston Medical Center, Boston University School of Medicine, Boston, MA.
Siracuse JJ; Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston University School of Medicine, Boston, MA. Electronic address: .; Pokaż więcej
Źródło :: Annals of vascular surgery [Ann Vasc Surg] 2021 Jan; Vol. 70, pp. 123-130. Date of Electronic Publication: 2020 May 13.
Typ publikacji :: Comparative Study; Journal Article
MeSH Terms :: Arteriovenous Shunt, Surgical*/adverse effects
Drug Substitution*
Renal Dialysis*/adverse effects
Anticoagulants/*administration & dosage
Heparin/*administration & dosage
Kidney Failure, Chronic/*therapy
Thrombosis/*prevention & control
Warfarin/*administration & dosage
Adult ; Aged ; Anticoagulants/adverse effects ; Drug Administration Schedule ; Female ; Heparin/adverse effects ; Humans ; Length of Stay ; Male ; Middle Aged ; Perioperative Care ; Postoperative Complications/etiology ; Retrospective Studies ; Time Factors ; Treatment Outcome ; Warfarin/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19.
Autorzy :: Liu Z; Department of Pulmonary and Critical Care Medicine, China Centre of Respiratory Medicine, National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Li X; Jinyintan Hospital, Wuhan, China.
Fan G; Department of Pulmonary and Critical Care Medicine, China Centre of Respiratory Medicine, National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China.
Zhou F; Department of Pulmonary and Critical Care Medicine, China Centre of Respiratory Medicine, National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Wang Y; Department of Pulmonary and Critical Care Medicine, China Centre of Respiratory Medicine, National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China.
Huang L; Department of Pulmonary and Critical Care Medicine, China Centre of Respiratory Medicine, National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China.
Yu J; Tsinghua University School of Medicine, Beijing, China.
Yang L; Tsinghua University School of Medicine, Beijing, China.
Shang L; Department of Pulmonary and Critical Care Medicine, China Centre of Respiratory Medicine, National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Beijing University of Chinese Medicine, Beijing, China.
Xie K; Department of Pulmonary and Critical Care Medicine, China Centre of Respiratory Medicine, National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China.
Xu J; Tsinghua University School of Medicine, Beijing, China.
Huang Z; Department of Pulmonary and Critical Care Medicine, China Centre of Respiratory Medicine, National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Gu X; Department of Pulmonary and Critical Care Medicine, China Centre of Respiratory Medicine, National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China.
Li H; Department of Pulmonary and Critical Care Medicine, China Centre of Respiratory Medicine, National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Zhang Y; Department of Pulmonary and Critical Care Medicine, China Centre of Respiratory Medicine, National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Wang Y; Department of Pulmonary and Critical Care Medicine, China Centre of Respiratory Medicine, National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Huang Z; Jinyintan Hospital, Wuhan, China. Electronic address: .
Cao B; Department of Pulmonary and Critical Care Medicine, China Centre of Respiratory Medicine, National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China; Tsinghua University School of Medicine, Beijing, China. Electronic address: .; Pokaż więcej
Źródło :: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2021 Jan; Vol. 27 (1), pp. 112-117. Date of Electronic Publication: 2020 Sep 29.
Typ publikacji :: Journal Article
MeSH Terms :: Adrenal Cortex Hormones/*therapeutic use
COVID-19/*drug therapy
COVID-19/*mortality
SARS-CoV-2/*pathogenicity
Aged ; Antiviral Agents/therapeutic use ; COVID-19/pathology ; China ; Critical Illness ; Drug Administration Schedule ; Female ; Hospital Mortality/trends ; Hospitals ; Humans ; Length of Stay/statistics & numerical data ; Male ; Middle Aged ; Proportional Hazards Models ; Respiration, Artificial ; Retrospective Studies ; SARS-CoV-2/drug effects ; Severity of Illness Index ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Best Practice for Delivering Small-Volume Intermittent Intravenous Infusions.
Autorzy :: Harding M; Kent State University Tuscarawas, New Philadelphia, Ohio (Dr Harding, Mss Stefka, Bailey, Morgan, and Mr Anderson); Trinity Hospital Twin City, Dennison, Ohio (Ms Stefka and Mr Anderson); Cleveland Clinic-Union Hospital, Dover, Ohio (Mss Bailey and Morgan). Mariann Harding, PhD, RN, CNE, FAADN, is a professor of nursing at Kent State University Tuscarawas. She teaches nursing fundamentals and medical-surgical nursing and oversees students' clinical experiences in surgical nursing. Dr Harding is also the lead editor for Lewis' Medical -Surgical Nursing, 10th edition, and coauthor of Clinical Reasoning Cases in Nursing. Shelly Stefka, MSN, RN, is a lecturer of nursing at Kent State University Tuscarawas and part-time staff member in medical-surgical nursing at Trinity Hospital Twin City in Dennison, Ohio. Ms Stefka teaches nursing fundamentals and medical-surgical nursing and oversees students' clinical experiences in surgical nursing. Mistey Bailey, MSN, RN, is a lecturer of nursing at Kent State University Tuscarawas. Ms Bailey teaches nursing fundamentals, medical-surgical nursing, and pediatrics, and oversees students' clinical experiences in surgical and pediatric nursing. Donna Morgan, BSN, RN, is the nursing laboratory coordinator at Kent State University Tuscarawas and a per diem staff nurse in labor and delivery at Cleveland Clinic-Union Hospital in Dover, Ohio. Ms Morgan is responsible for the oversight of nursing students' practice of laboratory skills, including intravenous therapy, and overseeing students' clinical experiences in obstetrics. She is currently a student at Kent State University, pursuing an MSN in nursing education. Aric Anderson, ASN, RN, was an honors student under the supervision of Dr Harding at the time this work was completed. He is currently a staff nurse in medical-surgical nursing at Trinity Hospital Twin City in Dennison, Ohio, and a student in the RN-BSN program at Kent State University.
Stefka S
Bailey M
Morgan D
Anderson A; Pokaż więcej
Źródło :: Journal of infusion nursing : the official publication of the Infusion Nurses Society [J Infus Nurs] 2020 Jan/Feb; Vol. 43 (1), pp. 47-52.
Typ publikacji :: Journal Article
MeSH Terms :: Drug Administration Schedule*
Pharmaceutical Preparations*
Practice Guidelines as Topic*
Infusions, Intravenous/*instrumentation
Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: 10-year outcome of temporary structured treatment interruption (STI) among HIV-1-infected patients: An observational study in a single medical center.
Autorzy :: Hsu WT; Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taiwan.
Pan SC; Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taiwan.
Hsieh SM; Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taiwan. Electronic address: .; Pokaż więcej
Źródło :: Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2020 Jan; Vol. 119 (1 Pt 3), pp. 455-461. Date of Electronic Publication: 2019 Aug 10.
Typ publikacji :: Journal Article; Observational Study
MeSH Terms :: Drug Administration Schedule*
Viral Load*
Anti-HIV Agents/*administration & dosage
HIV Infections/*drug therapy
Adult ; CD4 Lymphocyte Count ; Female ; Follow-Up Studies ; HIV-1 ; Humans ; Immunity, Cellular ; Male ; T-Lymphocytes/immunology ; Taiwan
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Drug Administration Schedule"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język